Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Fig. 2

Change from baseline in plasma concentrations of angiotensin II (Ang II) (a), Ang 1–7 (b), and Ang 1–5 (c) following treatment with placebo or GSK2586881 (recombinant human angiotensin-converting enzyme 2 [rhACE2]). Data are expressed as adjusted median ± 95% credible interval (CrI). n* is number of subjects available for each measurement

Back to article page

Critical Care

ISSN: 1364-8535